Product Images Atorvastatin Calcium

The text appears to be a graph showing the effect of Atorvastatin Calcium on the cumulative incidence of non-fatal myocardial infarction or coronary heart disease death. The graph displays the cumulative incidence in percentage for 5g with time in years from 10 to 35. The graph also shows that the hazard ratio (HR) is 0.64 with a confidence interval of 0.50-0.83 and a p-value of 0.0005. No further information is available to evaluate.*

The figure shows the effect of Atorvastatin Calcium 10 mg/day on the occurrence of major cardiovascular events such as myocardial infarction, acute coronary heart disease death, unstable angina, coronary revascularization, or stroke in CARDS study. The graph presents the cumulative hazard percentage over time to the first primary endpoint through four years of follow-up. The HR (Hazard Ratio) was 0.63, indicating a decreased risk of the primary endpoint with Atorvastatin Calcium.*

This is a figure showing the effect of Atorvastatin Calcium at a dosage of 80mg/day compared to 10mg/day on the time in years to the occurrence of major cardiovascular events. The percentage of subjects experiencing the event is displayed on the y-axis while the time to the first major cardiovascular endpoint is displayed on the x-axis. The graph displays a statistically significant decrease in the occurrence of major cardiovascular events with the higher dose of Atorvastatin Calcium.*

Atorvastatin Calcium Tablets is a medication used to reduce elevated total cholesterol, LDL-cholesterol, apolipoprotein B, and triglycerides levels. It contains 20mg of Atorvastatin Calcium, USP in each film-coated tablet. This medication should be kept out of reach of children and stored in a tight, child-resistant container at controlled room temperature. The NDC number for this medication is 63629-8470-1, and it is available in a pack of 500 tablets.*